Solutions by stage

Development Submission/Authorization Post-marketing

Specialized fields

Biotech Medical Cannabis

Main menu

QPPV

Safety Data Management

Signal and Benefit Risk

Medical Writing

Pharmacovigilance IT Systems

Safety Database

Clinical Safety

Local Pharmacovigilance

Regulatory Intelligence

Regulatory Intelligence

Pharmacovigilance Overview Clinical Safety Overview Quality Management Overview

Main menu

Regulatory Consulting

Regulatory Applications and Submissions

Regulatory Operations

Regulatory Affairs Overview

Main menu

GVP Auditing

Regulatory Inspections

Inspection Support

QA Management

QA Consulting

QA Consulting

SDEA/PVA Management

Quality Assurance and Auditing Overview

Resources.

Case studies.

View all

Regulatory Affairs

Delivering on our promise: ‘faster time to market’.

Medical writing, Non-clinical modules, Gap analysis

A Medical Writing project covering nine non-clinical modules (m2.4) for two products in different pharmaceutical forms and dosages.

Pharmacovigilance

Delivering enhanced Clinical Safety services.

Clinical Safety, Clinical Trials

Supporting an American pharmaceutical company with safety and efficacy in clinical trials

Auditing & QA

A proactive approach to passing a PV audit.

Project management, Gap analysis, Documentation

Regulatory Affairs

Automating request processing to drive transparency and speed.

Automation, Process improvement

Providing transparency on request status, time spent on each request, speeding processes and reducing error.

Downloads.

Latest news.

View all

Pharmacovigilance

Prabjot Hunjan is Arriello’s Director of Global Drug Safety.

Arriello welcomes high-profile Pharmacovigilance leader Prabjot Hunjan as Director of Global Drug Safety.

Company News

Arriello’s new office in Portugal.

The new space will cater for our growing number of operational and commercial #TeamYellow staff as we continue to build our physical presence in different locations.